设计和开发COX-II抑制剂:当前情景和未来的前景
Sandhya Chahal1, Payal Rani1, Kiran1
1Department of Chemistry, COBS&H, CCS Haryana Agricultural University, Hisar 125004, India.
ACS omega
|May 30, 2023
概括
环氧化原酶-II (COX-II) 抑制剂对于治疗炎症至关重要,但具有心血管风险. 本综述探讨了COX-II抑制剂支架,以指导开发更安全的下一代抗炎药物.
科学领域:
- 生物化学 生物化学
- 药理学 药理学是指药理学的学科.
- 药用化学 医学化学
背景情况:
- 天生的炎症有助于癌症和心血管疾病等慢性疾病.
- 循环氧化酶 (COX) 酶,特别是COX-II,是关键的炎症调解剂.
- 选择性COX-II抑制剂提供了改善的胃安全性,但面临心血管副作用.
研究的目的:
- 提供已知COX-II抑制剂的化学结构和抑制活性的概述.
- 为了解决对COX抑制剂支架多样性的有限系统性审查.
- 引导下一代COX-II抑制剂的开发,以提高安全性.
主要方法:
- 对有关COX-II抑制剂的现有文献进行系统审查.
- 分析化学结构和相关的抑制活动.
- 讨论已知的COX-II抑制剂中的支架多样性.
主要成果:
- 确定了COX-II抑制剂的各种化学支架.
- 突出了影响COX-II抑制的结构-活性关系.
- 提供了对药物开发的支架多样性的见解.
结论:
- 了解支架的多样性对于开发更安全的COX-II抑制剂至关重要.
- 下一代COX-II抑制剂需要强大的疗效和最小的心血管副作用.
- 这一评论作为未来抗炎药物发现研究的基础.
相关概念视频
Structure-Activity Relationships and Drug Design
801
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
801
Drug Discovery: Overview
8.1K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
8.1K
Drug Administration and Therapy Phases: Overview
564
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
564
Targets for Drug Action: Overview
6.5K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.5K
Pharmacodynamics: Overview and Principles
1.3K
Pharmacodynamics is a scientific field that delves into drugs' intricate biochemical, cellular, and physiological effects on the human body. The study of pharmacodynamics helps us understand how drugs interact with the body and elicit various responses.
Most drugs' effects result from their interactions with drug receptors or targets within the body. These interactions trigger specific responses at the cellular or systemic level. Drug receptors can be found on the surfaces of cells or...
Most drugs' effects result from their interactions with drug receptors or targets within the body. These interactions trigger specific responses at the cellular or systemic level. Drug receptors can be found on the surfaces of cells or...
1.3K
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
570
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
570


